{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/20/3348790/0/en/adaptin-bio-announces-opening-of-enrollment-in-a-phase-1-clinical-trial-evaluating-treatment-of-malignant-brain-tumors-with-aptn-101.html", "message": "News view counter 895216 successfully enlarged"}